Themis Medicare Ltd
Themis Medicare Ltd Share Price Today: Live Updates & Key Insights
Get insights on Themis Medicare Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Themis Medicare Ltd Share Price Chart
Themis Medicare Ltd Fundamentals
Traded Volume: 1,28,721
Market Cap(Cr): 1,069
Avg Traded Price 56.72
1 Year return -57.88%
Upper Circuit 118.4
Lower Circuit 113.9
P/E TTM -118.00
P/B Ratio -1.00
Traded Value(Cr) 149.51
EPS TTM -0.986
Book value -0.986
Dividend 0.00%
Themis Medicare Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Themis Medicare Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Themis Medicare Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -6.77%
1M -11.39%
3M +2.33%
1Y -57.88%
YTD -55.16%
Themis Medicare Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Themis Medicare Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 1.07L
Day Before Yesterday 73208.00
1W Avg 69638.50
1M Avg 8.65L
3M Avg 4.78L
Themis Medicare Ltd Technical Details
Themis Medicare Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 114
Support 2 112
Support 3 109
Pivot Point : 116
Resistance 1 118
Resistance 2 121
Resistance 3 123
Themis Medicare Ltd Corporate Actions
Themis Medicare Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Themis Medicare Ltd’s capital allocation strategies.
All
Ex-Date 04-Sep-2025 Type D Description 0.50/share@50.00% Record Date 05-Sep-2025 Ratio 50.00
Ex-Date 12-Jul-2024 Type D Description 0.50/share@50.00% Record Date 07-Nov-2025 Ratio 50.00
Ex-Date 10-Oct-2023 Type S Description share@1:10.00 Record Date 10-Oct-2023 Ratio 1:10.00
Ex-Date 01-Sep-2023 Type D Description 5.00/share@50.00% Record Date 07-Nov-2025 Ratio 50.00
Ex-Date 08-Sep-2022 Type D Description 5.00/share@50.00% Record Date 07-Nov-2025 Ratio 50.00
Ex-Date 08-Sep-2021 Type D Description 4.30/share@43.00% Record Date 07-Nov-2025 Ratio 43.00
Ex-Date 17-Sep-2020 Type D Description 1.75/share@17.50% Record Date 07-Nov-2025 Ratio 17.50
Ex-Date 20-Jul-2011 Type D Description 3.00/share@30.00% Record Date 07-Nov-2025 Ratio 30.00
Ex-Date 16-Jun-2010 Type D Description 3.00/share@30.00% Record Date 07-Nov-2025 Ratio 30.00
Ex-Date 01-Aug-2008 Type D Description 2.50/share@25.00% Record Date 07-Nov-2025 Ratio 25.00
Ex-Date 14-Sep-2007 Type D Description 2.00/share@20.00% Record Date 07-Nov-2025 Ratio 20.00
Dividends
Announcement Date 04-Sep-2025 Ex Dividend Date 04-Sep-2025 Dividend(%) 50
Announcement Date 12-Jul-2024 Ex Dividend Date 12-Jul-2024 Dividend(%) 50
Announcement Date 01-Sep-2023 Ex Dividend Date 01-Sep-2023 Dividend(%) 50
Announcement Date 08-Sep-2022 Ex Dividend Date 08-Sep-2022 Dividend(%) 50
Announcement Date 08-Sep-2021 Ex Dividend Date 08-Sep-2021 Dividend(%) 43
Announcement Date 17-Sep-2020 Ex Dividend Date 17-Sep-2020 Dividend(%) 18
Announcement Date 20-Jul-2011 Ex Dividend Date 20-Jul-2011 Dividend(%) 30
Announcement Date 16-Jun-2010 Ex Dividend Date 16-Jun-2010 Dividend(%) 30
Announcement Date 01-Aug-2008 Ex Dividend Date 01-Aug-2008 Dividend(%) 25
Announcement Date 14-Sep-2007 Ex Dividend Date 14-Sep-2007 Dividend(%) 20
Bonus
No Bonus has been declared by THEMISMED
Splits
Record Date 10-Oct-2023 Split Date 10-Oct-2023 Face Value (Before/After) 10.00/1.00
Others
Rights No Rights has been declared by THEMISMED
Themis Medicare Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Themis Medicare Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Themis Medicare Ltd's relative performance and valuation against major competitors.
Stock Name Sigachi Industries Ltd ₹35.77 (+0.08%) M. Cap (Cr) 13.67 1 Yr Return (%) -31.17% P/E (TTM) -24.83 PB Ratio 2.27
Stock Name Hester Biosciences Ltd ₹1601.80 (+0.65%) M. Cap (Cr) 13.63 1 Yr Return (%) -34.20% P/E (TTM) 36.25 PB Ratio 4.34
Stock Name Bliss GVS Pharma Ltd ₹127.90 (-15.84%) M. Cap (Cr) 13.51 1 Yr Return (%) -1.20% P/E (TTM) 12.33 PB Ratio 1.34
Stock Name Themis Medicare Ltd ₹116.15 (-1.82%) M. Cap (Cr) 10.69 1 Yr Return (%) -57.88% P/E (TTM) -117.85 PB Ratio 2.59
Stock Name Lincoln Pharmaceuticals Ltd ₹522.35 (-0.14%) M. Cap (Cr) 10.46 1 Yr Return (%) -23.56% P/E (TTM) 12.12 PB Ratio 1.56
Stock Name Remus Pharmaceuticals Ltd ₹806.20 (-0.61%) M. Cap (Cr) 9.50 1 Yr Return (%) -36.26% P/E (TTM) 32.68 PB Ratio 3.71
Stock Name NGL Fine Chem Ltd ₹1485.50 (+1.11%) M. Cap (Cr) 9.18 1 Yr Return (%) -26.56% P/E (TTM) 43.97 PB Ratio 3.25
Themis Medicare Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Themis Medicare Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 34.71 Mar 2024 22.04
PARTICULARS Investing Activities Mar 2025 -12.17 Mar 2024 -15.96
PARTICULARS Financing Activities Mar 2025 -25.90 Mar 2024 -8.77
PARTICULARS Net Cash Flow Mar 2025 -3.36 Mar 2024 -2.68
Themis Medicare Ltd Shareholding Pattern
This shows the ownership breakdown of Themis Medicare Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 67.15%
Public 32.77%
Other Institutions 0.01%
FII 0.06%
Mutual Funds null%
About Themis Medicare Ltd
Themis Medicare Limited was formerly incorporated as 'Themis Chemicals Limited' in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993. Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001. The Company is principally engaged in the business of manufacturing of finished formulations andsynthetic Active Pharmaceutical Ingredients.In Mar.'95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment long-term working capital.Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of anti-tuberculosis, cerebroactivators, bronchodilators, anti-asthmatic, anaesthetic and other segments.Anti-tuberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin, an anti-bacterial drug, for veterinary use for which it has a confirmed buy-back arrangement with Chinoin, Hungary.The company with the help of M/s Pharmograd,Moscow a manufacturing unit, is planning to market its Anti-T.B.formulation products through the collborators throughout the Russian Federation for trade,tenders and govt.supplies.The Company introduced products like Cardiac and Muscular Relaxant during the year 2001-02. A wholly owned subsidiary of the Company, Themis Medicare Singapore Pte. Ltd., formed on 22nd May, 2002 in Singapore became operational during the year 2002-03. M/s. Artemis Biotech Ltd., a Group Company was merged with Themis Medicare Ltd. (the Parent Company) with effect from 1st April 2003. The Joint Venture Company, Richter Themis Medicare (India) Pvt. Ltd. started manufacturing activities at its EOU unit at Vapi effective from March, 2006. The Company started operations of its new Injection Plant at Haridwar for tablets and gel formulation production in 2006-07. 'Themiseal', the Company's unique haemostatic and anti-microbial product was launched in the UK, Greece, Cyprus, Jordan, Romania and Indonesia.During the year 2010-11, a Private Ltd Subsidiary Company in the name and style of Themis Lifestyle Pvt. Ltd was incorporated on 3rd November, 2010 and another Public Ltd Subsidiary Company in the name and style of Artemis Biotech Ltd. was incorporated on 14th January, 2011.During FY 2016-17, HID-PUL KFT (Hungary), a Wholly Owned Subsidiary of the Company, ceased to be a subsidiary of the Company. Carpo Medical Limited was incorporated as a Joint Venture Company in the United Kingdom in 2016-17.The Company launched a new product - Lenzetto Global brand of Estradiol Novel Drug Delivery System for treatment of Menopausal symptoms in 2023. As part of a strategy to concentrate on both the API and the Hospital Business, the Company demerged the API segment of the Company, including both the API production facilities, to a 100% owned subsidiary company, Themis Lifestyle Private Limited through slump sale in 2023.
Chairman & Exec. Director
Dinesh S Patel
Registered office Plot No 69 A GIDC Indl Estate, Vapi, Valsad, Gujarat, 396195
FAX :91-260-2421675
Background
Incorporation Year 1969
Face Value ₹1.00
Market Lot 1
FAQs on Themis Medicare Ltd
How to buy Themis Medicare Ltd shares on NSE?
To buy Themis Medicare Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Themis Medicare Ltd share price today?
The Themis Medicare Ltd share price on NSE is ₹116.15 today.
What is the market cap of Themis Medicare Ltd on NSE?
The company has a market capitalization of ₹1069.05.
What is the PE & PB ratio of Themis Medicare Ltd?
PE is -118 and PB is -1.
What is the 52 Week High and Low of Themis Medicare Ltd shares?
Themis Medicare Ltd stock price high: ₹317 Themis Medicare Ltd stock price low: ₹98.